• Home
  •  / Caixa Capital Risc
ProfileJobs

Caixa Capital Risc

Suggest Edit

Caixa Capital Risc is an institutional investor specializing in innovative early-stage companies. The company manages four investment funds: Caixa Capital Micro, Caixa Capital BioMed, Caixa Innvierte Industria, and Caixa Capital TIC. Caixa Capital Risc carries out activities together with other public and private entities, to encourage and promote enterprises and the creation of innovative companies in Spain.

Through different specialized vehicles we invest in the seed phase and support during the Series A and B rounds, if necessary.

Caixa Capital Risc manages a capital of 154 million euro and invests mainly in Spanish companies in the following fields:

  • TIME: corporate software, communications equipment, and Internet/mobile business
  • Healthcare/ Life sciences: therapeutic treatments, drug development, medical devices, and healthcare services
  • Industrial technology: new materials, sustainability, process technology, etc.
Show more
TypeInvestor
Founded2004
Websitecaixacapitalrisc.es
Cybersecurity ratingAMore
Caixa Capital Risc was founded in 2004

Viewing summary data as a guest

Sign up for free to see all data

Caixa Capital Risc Investment Portfolio

Stage Distribution

20102021

Top Sectors Distribution

20102021

Round Size Distribution

20102021
Show more

Caixa Capital Risc Online and Social Media Presence

Caixa Capital Risc's Trends

Embed Graph

Caixa Capital Risc Blogs

June 04, 2019

Minoryx Therapeutics anuncia la primera dosis de un paciente en el ensayo FRAMES fase 2 en la Ataxia de Friedreich [Artículo en inglés]

4 de junio de 2019- Minoryx Therapeutics, una compañía especializada en el desarrollo de nuevos medicamentos para enfermedades huérfanas, anuncia hoy que el primer paciente ha recibido la dosis de su candidato principal, la leriglitazona (MIN-102), en la fase 2 del ensayo clínico FRAMES en la ataxia…
March 12, 2019

Minoryx Therapeutics nombra a Didier Le Normand como Director Financiero (CFO) del Grupo y Director General de su filial belga [Artículo en inglés]

Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces that it has appointed Didier Le Normand as Group CFO as well as General Manager of its recently opened Belgian subsidiary. Didier Le Normand started his career in banking in ...
February 28, 2019

Minoryx Therapeutics recibe la aprobación de la Agencia Española de Medicamentos y Productos Sanitarios para iniciar el estudio de Fase 2 en la Ataxia de Friedreich. [Artículo en inglés]

Se espera que el ensayo FRAMES inicie el reclutamiento de pacientes en las próximas semanas en España, Bélgica y otros países europeos. Dos líderes de opinión se unen al consejo asesor científico de Minoryx. En 2018, Minoryx cerró una ronda de financiación de la Serie B de € 21.3M para expandir el d…

 Caixa Capital Risc Frequently Asked Questions

  • When was Caixa Capital Risc founded?

    Caixa Capital Risc was founded in 2004.